Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action

Science Translational Medicine

Volumn 5, Issue 170, 2013, Pages

  Lindtner, Claudia ^a   Scherer, Thomas ^a,b   Zielinski, Elizabeth ^a   Filatova, Nika ^a   Fasshauer, Martin ^a   Tonks, Nicholas K ^c   Puchowicz, Michelle ^d   Buettner, Christoph ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; GLUCOSE; INSULIN RECEPTOR; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE 1B;

ALCOHOL BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BINGE DRINKING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HORMONE ACTION; HYPOTHALAMUS FUNCTION DISORDER; INSULIN RESISTANCE; LIPOLYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; BINGE DRINKING; BODY WEIGHT; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIVER; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RATS; SIGNAL TRANSDUCTION;

EID: 84874104450     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005123     Document Type: Article

References (61)

1. S. Carlsson, N. Hammar, V. Grill, J. Kaprio, Alcohol consumption and the incidence of type 2 diabetes: A 20-year follow-up of the Finnish twin cohort study. Diabetes Care 26, 2785-2790 (2003).
2. A. Z. Fan, M. Russell, T. Naimi, Y. Li, Y. Liao, R. Jiles, A. H. Mokdad, Patterns of alcohol consumption and the metabolic syndrome. J. Clin. Endocrinol. Metab. 93, 3833-3838 (2008).
3. K. Lee, Gender-specific relationships between alcohol drinking patterns and metabolic syndrome: The Korea National Health and Nutrition Examination Survey 2008. Public Health Nutr. 15, 1917-1924 (2012).
4. M. Cullmann, A. Hilding, C. G. Östenson, Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population. Diabet. Med. 29, 441-452 (2012).
5. T. S. Naimi, R. D. Brewer, A. Mokdad, C. Denny, M. K. Serdula, J. S. Marks, Binge drinking among US adults. JAMA 289, 70-75 (2003).
6. M. Mitka, College binge drinking still on the rise. JAMA 302, 836-837 (2009).
7. S. Pincock, Binge drinking on rise in UK and elsewhere. Government report shows increases in alcohol consumption, cirrhosis, and premature deaths. Lancet 362, 1126-1127 (2003).
8. N. D. Volkow, G. J. Wang, R. D. Baler, Reward, dopamine and the control of food intake: Implications for obesity. Trends Cogn. Sci. 15, 37-46 (2011).
9. S. D. Mittelman, R. N. Bergman, Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am. J. Physiol. Endocrinol. Metab. 279, E630-E637 (2000).
10. S. Obici, B. B. Zhang, G. Karkanias, L. Rossetti, Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8, 1376-1382 (2002).
11. T. Scherer, J. O'Hare, K. Diggs-Andrews, M. Schweiger, B. Cheng, C. Lindtner, E. Zielinski, P. Vempati, K. Su, S. Dighe, T. Milsom, M. Puchowicz, L. Scheja, R. Zechner, S. J. Fisher, S. F. Previs, C. Buettner, Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 13, 183-194 (2011).
12. J. D. O'Hare, E. Zielinski, B. Cheng, T. Scherer, C. Buettner, Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis. Diabetes 60, 1055-1062 (2011).
13. H. Okamoto, S. Obici, D. Accili, L. Rossetti, Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J. Clin. Invest. 115, 1314-1322 (2005).
14. N. K. Tonks, PTP1B: From the sidelines to the front lines! FEBS Lett. 546, 140-148 (2003).
15. S. Kipfer-Coudreau, D. Eberlé, M. Sahbatou, A. Bonhomme, B. Guy-Grand, P. Froguel, P. Galan, A. Basdevant, K. Clément, Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia 47, 1278-1284 (2004).
16. R. C. Tsou, K. K. Bence, The genetics of PTPN1 and obesity: Insights from mouse models of tissue-specific PTP1B deficiency. J. Obes. 2012, 926857 (2012).
17. M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A. L. Loy, D. Normandin, A. Cheng, J. Himms-Hagen, C. C. Chan, C. Ramachandran, M. J. Gresser, M. L. Tremblay, B. P. Kennedy, Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548 (1999).
18. M. Delibegovic, D. Zimmer, C. Kauffman, K. Rak, E. G. Hong, Y. R. Cho, J. K. Kim, B. B. Kahn, B. G. Neel, K. K. Bence, Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 58, 590-599 (2009).
19. K. K. Bence, M. Delibegovic, B. Xue, C. Z. Gorgun, G. S. Hotamisligil, B. G. Neel, B. B. Kahn, Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 12, 917-924 (2006).
20. O. Tschritter, H. Preissl, A. M. Hennige, M. Stumvoll, K. Porubska, R. Frost, H. Marx, B. Klösel, W. Lutzenberger, N. Birbaumer, H. U. Häring, A. Fritsche, The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: A magnetoencephalographic study. Proc. Natl. Acad. Sci. U.S.A. 103, 12103-12108 (2006).
21. M. Guthoff, K. T. Stingl, O. Tschritter, M. Rogic, M. Heni, K. Stingl, M. Hallschmid, H. U. Häring, A. Fritsche, H. Preissl, A. M. Hennige, The insulin-mediated modulation of visually evoked magnetic fields is reduced in obese subjects. PLoS One 6, e19482 (2011).
22. J. C. Brüning, D. Gautam, D. J. Burks, J. Gillette, M. Schubert, P. C. Orban, R. Klein, W. Krone, D. Müller-Wieland, C. R. Kahn, Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122-2125 (2000).
23. T. Scherer, C. Lindtner, E. Zielinski, J. O'Hare, N. Filatova, C. Buettner, Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J. Biol. Chem. 287, 33061-33069 (2012).
24. S. E. Shoelson, J. Lee, A. B. Goldfine, Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801 (2006).
25. J. P. Thaler, M. W. Schwartz, Minireview: Inflammation and obesity pathogenesis: The hypothalamus heats up. Endocrinology 151, 4109-4115 (2010).
26. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, D. Cai, Hypothalamic IKKb/NF-kB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73 (2008).
27. L. Ozcan, A. S. Ergin, A. Lu, J. Chung, S. Sarkar, D. Nie, M. G. Myers Jr., U. Ozcan, Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9, 35-51 (2009).
28. A. Avogaro, A. Valerio, M. Miola, C. Crepaldi, P. Pavan, A. Tiengo, S. del Prato, Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism. J. Clin. Endocrinol. Metab. 81, 2285-2290 (1996).
29. G. Boden, X. Chen, R. A. DeSantis, Z. Kendrick, Ethanol inhibits insulin action on lipolysis and on insulin release in elderly men. Am. J. Physiol. 265, E197-E202 (1993).
30. Y. Onishi, M. Honda, T. Ogihara, H. Sakoda, M. Anai, M. Fujishiro, H. Ono, N. Shojima, Y. Fukushima, K. Inukai, H. Katagiri, M. Kikuchi, Y. Oka, T. Asano, Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation. Biochem. Biophys. Res. Commun. 303, 788-794 (2003).
31. J. J. Shelmet, G. A. Reichard, C. L. Skutches, R. D. Hoeldtke, O. E. Owen, G. Boden, Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. J. Clin. Invest. 81, 1137-1145 (1988).
32. A. Avogaro, R. M. Watanabe, A. Dall'Arche, S. V. De Kreutzenberg, A. Tiengo, G. Pacini, Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects. Diabetes Care 27, 1369-1374 (2004).
33. J. J. Callaci, R. Himes, K. Lauing, P. Roper, Long-term modulations in the vertebral transcriptome of adolescent-stage rats exposed to binge alcohol. Alcohol Alcohol. 45, 332-346 (2010).
34. C. H. Lang, R. A. Frost, T. C. Vary, Acute alcohol intoxication increases REDD1 in skeletal muscle. Alcohol. Clin. Exp. Res. 32, 796-805 (2008).
35. D. J. Knapp, C. J. Braun, G. E. Duncan, Y. Qian, A. Fernandes, F. T. Crews, G. R. Breese, Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immuno-histochemistry and differential routes of drug administration. Alcohol. Clin. Exp. Res. 25, 1662-1672 (2001).
36. B. E. Leonard, Is ethanol a neurotoxin?: The effects of ethanol on neuronal structure and function. Alcohol Alcohol. 21, 325-338 (1986).
37. C. Benedict, W. Kern, B. Schultes, J. Born, M. Hallschmid, Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 93, 1339-1344 (2008).
38. S. D. Mittelman, R. N. Bergman, Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am. J. Physiol. Endocrinol. Metab. 279, E630-E637 (2000).
39. L. Kang, X. Chen, B. M. Sebastian, B. T. Pratt, I. R. Bederman, J. C. Alexander, S. F. Previs, L. E. Nagy, Chronic ethanol and triglyceride turnover in white adipose tissue in rats: Inhibition of the antilipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J. Biol. Chem. 282, 28465-28473 (2007).
40. J. M. Zabolotny, F. G. Haj, Y. B. Kim, H. J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, B. B. Kahn, Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J. Biol. Chem. 279, 24844-24851 (2004).
41. P. J. Klover, T. A. Zimmers, L. G. Koniaris, R. A. Mooney, Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784-2789 (2003).
42. J. J. Senn, P. J. Klover, I. A. Nowak, T. A. Zimmers, L. G. Koniaris, R. W. Furlanetto, R. A. Mooney, Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740-13746 (2003).
43. G. S. Hotamisligil, A. Budavari, D. Murray, B. M. Spiegelman, Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-a. J. Clin. Invest. 94, 1543-1549 (1994).
44. S. Oh-I, J. P. Thaler, K. Ogimoto, B. E. Wisse, G. J. Morton, M. W. Schwartz, Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am. J. Physiol. Endocrinol. Metab. 299, E47-E53 (2010).
45. T. B. Mark, A. T. Blaskovich, T. Baughman, T. Little, W. Patt, M. Qaber, L. M. Schultz, G. Nagula, J. L. Gage, J. J. Howbert, Protein tyrosine phosphatase inhibitors and methods of use thereof, U.S. Patent 7504389 (2009).
46. G. F. Lewis, M. Vranic, P. Harley, A. Giacca, Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46, 1111-1119 (1997).
47. D. S. Quintana, I. S. McGregor, A. J. Guastella, G. S. Malhi, A. H. Kemp, A meta-analysis on the impact of alcohol dependence on short-term resting-state heart rate variability: Implications for cardiovascular risk. Alcohol. Clin. Exp. Res. 37, E23-E29 (2013).
48. P. van de Borne, A. L. Mark, N. Montano, D. Mion, V. K. Somers, Effects of alcohol on sympathetic activity, hemodynamics, and chemoreflex sensitivity. Hypertension 29, 1278-1283 (1997).
49. G. Mancia, P. Bousquet, J. L. Elghozi, M. Esler, G. Grassi, S. Julius, J. Reid, P. A. Van Zwieten, The sympathetic nervous system and the metabolic syndrome. J. Hypertens. 25, 909-920 (2007).
50. A. E. Seiler, A. Henderson, R. Rubin, Ethanol inhibits insulin receptor tyrosine kinase. Alcohol. Clin. Exp. Res. 24, 1869-1872 (2000).
51. M. Tong, L. Longato, Q.-G. Nguyen, W. C. Chen, A. Spaisman, S. M. de la Monte, Acetaldehyde-mediated neurotoxicity: Relevance to fetal alcohol spectrum disorders. Oxid. Med. Cell. Long. 2011, 1-13 (2011).
52. M. García-San Frutos, T. Fernández-Agulló, J. M. Carrascosa, D. Horrillo, M. T. Barrús, E. Oliveros, J. Sierra, M. Ros, Involvement of protein tyrosine phosphatases and inflammation in hypothalamic insulin resistance associated with ageing: Effect of caloric restriction. Mech. Ageing Dev. 133, 489-497 (2012).
53. C. L. White, A. Whittington, M. J. Barnes, Z. Wang, G. A. Bray, C. D. Morrison, HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and -independent mechanisms. Am. J. Physiol. Endocrinol. Metab. 296, E291-E299 (2009).
54. S. Schenk, M. Saberi, J. M. Olefsky, Insulin sensitivity: Modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992-3002 (2008).
55. A. González-Rodríguez, J. A. Más-Gutierrez, M. Mirasierra, A. Fernandez-Pérez, Y. J. Lee, H. J. Ko, J. K. Kim, E. Romanos, J. M. Carrascosa, M. Ros, M. Vallejo, C. M. Rondinone, A. M. Valverde, Essential role of protein tyrosine phosphatase 1B in obesity-induced inflammation and peripheral insulin resistance during aging. Aging Cell 11, 284-296 (2012).
56. T. Smith, E. G. DeMaster, J. K. Furne, J. Springfield, M. D. Levitt, First-pass gastric mucosal metabolism of ethanol is negligible in the rat. J. Clin. Invest. 89, 1801-1806 (1992).
57. K. Ogilvie, S. Lee, C. Rivier, Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis. Alcohol. Clin. Exp. Res. 21, 467-476 (1997).
58. G. Gadeholt, A. Stowell, J. Mørland, Acute ethanol intoxication decreases subsequent food intake and changes hepatic microsomal enzyme activities similarly to fasting. Acta Pharmacol. Toxicol. 53, 417-420 (1983).
59. G. Paxinos, The Rat Brain in Stereotaxic Coordinates (Academic Press, Waltham, MA, ed. 6, 2009).
60. M. Stumvoll, S. Jacob, Multiple sites of insulin resistance: Muscle, liver and adipose tissue. Exp. Clin. Endocrinol. Diabetes 107, 107-110 (1999).
61. T method. Nat. Protoc. 3, 1101-1108 (2008).